Comparison of post-COVID-19 vaccination hypermetabolic lymphadenopathy on 18F-fluorodeoxyglucose PET/CT between virus-vector vaccine and mRNA vaccine
Meng-Ting Chiang, Jann-Tay Wang, Wan-Yu Lin, Ruoh-Fang Yen, Jei-Yie Huang, Ching-Chu Lu · 2023
Read Comparison of post-COVID-19 vaccination hypermetabolic lymphadenopathy on 18F-fluorodeoxyglucose PET/CT between virus-vector vaccine and mRNA vaccine by Meng-Ting Chiang, Jann-Tay Wang, Wan-Yu Lin, Ruoh-Fang Yen, Jei-Yie Huang, Ching-Chu Lu (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10647177.txt.
Description
PurposeWe compared hypermetabolic lymphadenopathy (HLN) on 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) after virus-vector and mRNA vaccines for coronavirus disease 2019 (COVID-19).MethodsThis retrospective study included 573 participants who underwent FDG PET/CT after receiving a virus-vector vaccine (ChAdOx1, AstraZeneca [AZ] group) or an mRNA vaccine (mRNA-1273, Moderna [M] group) from July 2021 to October 2021.
Catalog record
| CREATOR | Meng-Ting Chiang, Jann-Tay Wang, Wan-Yu Lin, Ruoh-Fang Yen, Jei-Yie Huang, Ching-Chu Lu |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |